GLP-1 Market Companies Novo Nordisk Eli Lilly and Company Zealand Pharma Structure Therapeutics Amgen Viking Therapeutics Sanofi AstraZeneca Hansoh Pharmaceutical Group Co
Unlike GLP-1 medications, which are primarily designed for diabetes and weight loss, LDN offers broader therapeutic benefits, including immune system regulation and pain management
However, the remarkably low utilization of GLP-1 RAs among these patients, as shown in this study, underscores an urgent need to heighten awareness and implementation of this therapeutic approach
Learn more about how Gallup Panel works.
That does not mean oral options can never work, but injections currently offer the best-documented outcomes
Many people find that injecting cold liquid can cause a slight stinging sensation